Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background A growing body of evidence suggests that repetitive transcranial magnetic stimulation (rTMS) can alleviate negative and positive symptoms of refractory schizophrenia. However, trials to date have been small and results are mixed. Methods We performed meta-analyses of all prospective studies of the therapeutic application of rTMS in refractory schizophrenia assessing the effects of high-frequency rTMS to the left dorsolateral prefrontal cortex (DLPFC) to treat negative symptoms, and low-frequency rTMS to the left temporo-parietal cortex (TPC) to treat auditory hallucinations (AH) and overall positive symptoms. Results When analyzing controlled (active arms) and uncontrolled studies together, the effect sizes showed significant and moderate effects of rTMS on negative and positive symptoms (based on PANSS-N or SANS, and PANSS-P or SAPS, respectively). However, the analysis for the sham-controlled studies revealed a small non-significant effect size for negative (0.27, p=0.417) and for positive symptoms (0.17, p=0.129). When specifically analyzing AH (based on AHRS, HCS or SAH), the effect size for the sham-controlled studies was large and significant (1.04; p=0.002). Conclusions These meta-analyses support the need for further controlled, larger trials to assess the clinical efficacy of rTMS on negative and positive symptoms of schizophrenia, while suggesting the need for exploration for alternative stimulation protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Strafella, A. P., Paus, T., Barrett, J., & Dagher, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-j0003.2001 · Cited by 1,058
Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919 · cited 1×
“These two domains of cognition are among those identified by the NIMH-MATRICS project as important for schizophrenia (Green and Nuechterlein, 2004; Green et al., 2004).”
BackgroundA functional neuroanatomy of hallucinations in schizophrenia
Silbersweig, D. A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grootoonk, S., Seaward, J., McKenna, P., Chua, S. E., Schnorr, L., et al. (1995) · Nature · doi:10.1038/378176a0 · Cited by 906 · cited 1×
“…2001), which may underlie improvement of negative symptoms (Heimer et al., 1997), whereas positive correlations between increased temporal cortical activity and the hallucinating state in schizophrenics have been reported (e.g., Silbersweig et al., 1995; Dierks et al., 1999; Shergill et al., 2000).”
BackgroundThe role of the cerebellum in schizophrenia
Andreasen, N. C., & Pierson, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.003 · Cited by 669 · cited 1×
“Indeed, Andreasen and Pierson (2008) extensively reviewed several lines of evidence for cerebellar abnormalities in schizophrenia and argued its role in the modulation of higher cognitive processes, largely impaired in schizophrenics.”
BackgroundMapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging
Shergill, S. S., Brammer, M. J., Williams, S. C. R., Murray, R. M., & McGuire, P. K. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1033 · Cited by 666 · cited 2×
“, 1997), whereas positive correlations between increased temporal cortical activity and the hallucinating state in schizophrenics have been reported (e.g., Silbersweig et al., 1995; Dierks et al., 1999; Shergill et al., 2000).”
BackgroundKarlsgodt, K. H., van Erp, T. G. M., Poldrack, R. A., Bearden, C. E., Nuechterlein, K. H., & Cannon, T. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.017 · Cited by 335
Hoffman, R. E., Gueorguieva, R., Hawkins, K. A., Varanko, M., Boutros, N. N., Wu, Y.-T., Carroll, K., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.041 · Cited by 272
Huang, Y.-Z., & Rothwell, J. C. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.12.026 · Cited by 197 · cited 2×
“In this respect, modified parameters of rTMS that lead to longer-lasting cortical modulation, such as theta-burst stimulation (Huang and Rothwell, 2004), would seem worth testing.”
BackgroundOrbitofrontal volume deficit in schizophrenia and thought disorder
Nakamura, M., Nestor, P. G., Levitt, J. J., Cohen, A. S., Kawashima, T., Shenton, M. E., & McCarley, R. W. (2007) · Brain · doi:10.1093/brain/awm265 · Cited by 186
Cited by
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W., Shergill, S., & McGuire, P. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu170 · Cited by 683
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Brunelin, J., Mondino, M., Gassab, L., Haesebaert, F., Gaha, L., Suaud-Chagny, M.-F., Saoud, M., Mechri, A., & Poulet, E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11071091 · Cited by 520
Kuo, M.-F., Paulus, W., & Nitsche, M. A. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.117 · Cited by 415
Fox, M. D., Halko, M. A., Eldaief, M. C., & Pascual-Leone, A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.035 · Cited by 395
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
Demirtas-Tatlidede, A., Vahabzadeh-Hagh, A. M., & Pascual-Leone, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.020 · Cited by 236
“For positive symptoms (specifically auditory hallucinations ), the goal was to inhibit the left temporoparietal cortex via 1 Hz rTMS, based on the rationale that increased temporal activity correlates with positive symptoms (for a review see Freitas et al., 2009).”
Bersani, F. S., Minichino, A., Enticott, P. G., Mazzarini, L., Khan, N., Antonacci, G., Raccah, R. N., Salviati, M., Delle Chiaie, R., Bersani, G., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.02.006 · Cited by 169
“symptoms treated with standard TMS [9,28,78].”
Slotema, C. W., Blom, J. D., de Weijer, A. D., Diederen, K. M., Goekoop, R., Looijestijn, J., Daalman, K., Rijkaart, A.-M., Kahn, R. S., Hoek, H. W., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.051 · Cited by 137
Transcranial magnetic stimulation: A neuroscientific probe of cortical function in schizophrenia
McClintock, S. M., Freitas, C., Oberman, L., Lisanby, S. H., & Pascual-Leone, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.031 · Cited by 101
Self-citationGarg, S., Sinha, V. K., Tikka, S. K., Mishra, P., & Goyal, N. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.023 · Cited by 95
Levkovitz, Y., Rabany, L., Harel, E. V., & Zangen, A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000642 · Cited by 87
“However, even though specific parameters (such as treatment duration and frequency) have been found to improve clinical outcomes (Dlabac-de Lange et al. 2010), recent reviews (Blumberger et al. 2010; Freitas et al. 2009; Stanford et al. 2008), reported moderate improvement of negative symptoms.”
BackgroundRepetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients
Prikryl, R., Ustohal, L., Kucerova, H. P., Kasparek, T., Jarkovsky, J., Hublova, V., Vrzalova, M., & Ceskova, E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.019 · Cited by 79
Prikryl, R., Ustohal, L., Prikrylova Kucerova, H., Kasparek, T., Venclikova, S., Vrzalova, M., & Ceskova, E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.06.015 · Cited by 66
Chauhan, P., Garg, S., Tikka, S. K., & Khattri, S. (2021) · The Cerebellum · doi:10.1007/s12311-020-01193-9 · Cited by 57
Boggio, P. S., Asthana, M. K., Costa, T. L., Valasek, C. A., & Osório, A. A. C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00294 · Cited by 27
Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?
Taylor, J. J., Krystal, J. H., D'Souza, D. C., Gerrard, J. L., & Corlett, P. R. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.020 · Cited by 5
“There is emerging evidence that TMS may reduce AH in patients with schizophrenia and related psychotic disorders (Freitas et al., 2009; Hoffman et al., 2003; Hoffman et al., 2013; Montagne-Larmurier et al., 2011; Otani et al., 2015; Slotema et al., 2014).”
Metadata
- Authors
- Freitas, C., Fregni, F., & Pascual-Leone, A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 108
- Issue
- 1-3
- Pages
- 11-24
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1969605556
- Cited by
- 251
- References
- 11
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.